Jump to content

Up to 4 million women with irregular periods should be investigated for polyendocrine metabolic ovarian syndrome, according to new NHS guidance.

PMOS, previously known as polycystic ovarian syndrome, is believed to affect up to 13% of reproductive age women, the World Health Organization estimates.

Symptoms include irregular, very short, long or absent periods, excess levels of testosterone, and ovaries with multiple small follicles.

The condition is associated with greater risk of developing type 2 diabetes, cardiovascular disease, sleep apnoea, fatty liver disease, mental health issues and complications in pregnancy.

Read full story

Source: Guardian, 1 July 2026

0 Comments


Recommended Comments

There are no comments to display.


Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.